马来酸麦角新碱三针法在瘢痕子宫再次妊娠产妇中的应用效果(1)
[摘要]目的 探討马来酸麦角新碱三针法在瘢痕子宫再次妊娠产妇中的应用效果。方法 选取2016年10月～2018年10月我院收治的146例瘢痕子宫再次妊娠(单胎、足月、剖宫产)产妇作为研究对象，按照随机数字表法分为对照组(73例)与观察组(73例)，对照组采用缩宫素持续静脉滴注，观察组采用马来酸麦角新碱三针法，比较两组的生化指标、产程、临床疗效、产后出血及不良反应发生情况。结果 两组术后的血红蛋白水平均低于术前，差异有统计学意义(P<0.05);观察组术后的血红蛋白水平高于对照组，差异有统计学意义(P<0.05);观察组的第三产程、术后住院时间短于对照组，治疗总有效率高于对照组，术中出血量、产后2 h出血量、产后24 h出血量少于对照组，不良反应总发生率低于对照组，差异均有统计学意义(P<0.05)。结论 马来酸麦角新碱三针法可缩短瘢痕子宫再次妊娠产妇的产程，减少出血量，疗效好且安全性高。
[关键词]马来酸麦角新碱;瘢痕子宫;产后出血;缩宫素;不良反应
[中图分类号] R714 [文献标识码] A [文章编号] 1674-4721(2020)8(a)-0104-04
Application effect of three-dose regimen of Ergometrine Maleate in re-pregnant women with scarred uterus
ZHANG Ji-hong LUO Xu-qing▲ DONG Chun-yan
Department of Obstetrics and Gynecology， Maternal and Child Health Hospital of Xinyu， Jiangxi Province， Xinyu 338000， China
[Abstract] Objective To investigate the application effect of three-dose regimen of Ergometrine Maleate in re-pregnant women with scarred uterus. Methods A total of 146 re-pregnant women with scarred uterus (singleton pregnancy， full-term， cesarean section) treated in our hospital from October 2016 to October 2018 were selected as research subjects. They were divided into the control group (n=73) and the observation group (n=73) by the random number table method. The control group received continuous intravenous infusion of Oxytocin， and the observation group received three-dose regimen of Ergometrine Maleate. The biochemical indicators， labor stage， clinical efficacy， postpartum hemorrhage and adverse reactions of the two groups were compared. Results The hemoglobin levels after surgery of the two groups were lower than those before surgery， and the differences were statistically significant (P<0.05). The hemoglobin level after surgery in the observation group was higher than that of the control group， and the difference was statistically significant (P<0.05). The third stage of labor and postoperative hospital stay in the observation group were shorter than those in the control group， the total effective rate of treatment was higher than that in the control group， the intraoperative blood loss， 2 h postpartum hemorrhage， and 24 h postpartum hemorrhage were less than those in the control group， and the total incidence of adverse reactions was lower than that in the control group， the differences were statistically significant (P<0.05). Conclusion The three-dose regimen of Ergometrine Maleate can shorten the labor stage of re-pregnant women with scarred uterus and reduce bleeding， with favorable therapeutic effect and high safety., 百拇医药(张继红 罗序清 董春燕)
[关键词]马来酸麦角新碱;瘢痕子宫;产后出血;缩宫素;不良反应
[中图分类号] R714 [文献标识码] A [文章编号] 1674-4721(2020)8(a)-0104-04
Application effect of three-dose regimen of Ergometrine Maleate in re-pregnant women with scarred uterus
ZHANG Ji-hong LUO Xu-qing▲ DONG Chun-yan
Department of Obstetrics and Gynecology， Maternal and Child Health Hospital of Xinyu， Jiangxi Province， Xinyu 338000， China
[Abstract] Objective To investigate the application effect of three-dose regimen of Ergometrine Maleate in re-pregnant women with scarred uterus. Methods A total of 146 re-pregnant women with scarred uterus (singleton pregnancy， full-term， cesarean section) treated in our hospital from October 2016 to October 2018 were selected as research subjects. They were divided into the control group (n=73) and the observation group (n=73) by the random number table method. The control group received continuous intravenous infusion of Oxytocin， and the observation group received three-dose regimen of Ergometrine Maleate. The biochemical indicators， labor stage， clinical efficacy， postpartum hemorrhage and adverse reactions of the two groups were compared. Results The hemoglobin levels after surgery of the two groups were lower than those before surgery， and the differences were statistically significant (P<0.05). The hemoglobin level after surgery in the observation group was higher than that of the control group， and the difference was statistically significant (P<0.05). The third stage of labor and postoperative hospital stay in the observation group were shorter than those in the control group， the total effective rate of treatment was higher than that in the control group， the intraoperative blood loss， 2 h postpartum hemorrhage， and 24 h postpartum hemorrhage were less than those in the control group， and the total incidence of adverse reactions was lower than that in the control group， the differences were statistically significant (P<0.05). Conclusion The three-dose regimen of Ergometrine Maleate can shorten the labor stage of re-pregnant women with scarred uterus and reduce bleeding， with favorable therapeutic effect and high safety., 百拇医药(张继红 罗序清 董春燕)